Clariscan (gadoterate meglumine) is a macrocyclic, gadolinium-based contrast agent developed with the expertise and quality of GE HealthCare. Designed to enhance the visualization of tissues during magnetic resonance imaging (MRI), Clariscan delivers consistent, high-quality images across a wide range of clinical indications.